Peptides for ADHD: what the evidence actually says

What did @shoorahj actually say?

The creator says she stopped tolerating Adderall and other stimulant substitutes around age 50 and turned to two peptide nasal sprays, semax and selank, sourced through Valhalla Vitality and compounded at Revived Pharmacy. She reports that within 30 to 60 minutes of dosing on high-brain-fog days, she notices clearer thinking and less mental fog, without heart racing, jitteriness, insomnia, or cotton mouth. She calls them "proven in many studies" to help people with ADHD and notes that they are used clinically in Russia and mandated for stroke-related cognitive recovery in some countries. She is not a medical professional and says so clearly, framing everything as personal experience.

Does the science back this up?

Partially, but the evidence base is narrow and almost entirely preclinical or Russian-language. That matters a lot. Semax is a synthetic analogue of ACTH(4-7), originally developed in Russia in the 1980s. It does have documented effects on brain-derived neurotrophic factor (BDNF) and dopaminergic signaling, which are relevant to attention and executive function. Selank is a synthetic analogue of tuftsin and has been studied primarily for anxiolytic effects. Neither has completed a randomized controlled trial in ADHD populations that meets Western regulatory standards.

• Dolotov et al. (2006, Neuroscience) showed semax increased BDNF expression in rat hippocampus and frontal cortex, regions relevant to attention regulation.
• Volkova et al. (2016, Molecular Biology) documented semax effects on serotonin and dopamine transporter expression in animal models, but human translation is unconfirmed.
• Semenova et al. (2010, CNS Drug Reviews) reviewed selank's anxiolytic and nootropic properties in Russian clinical settings, noting small-scale positive findings but no large-scale placebo-controlled trials.

The phrase "proven in many studies" overstates the current evidence considerably. Small Russian studies are not the same as replicated, peer-reviewed Phase III trials.

What did they get wrong (or right)?

She got the Russia origin right, and the stroke rehabilitation use is accurate for semax specifically, which is approved by the Russian Ministry of Health for ischemic stroke recovery. The claim that these peptides are "proven in many studies" to help ADHD is where she overshoots. There are no published human RCTs specifically in ADHD populations in any major indexed journal. The mechanism is plausible, the preliminary data is interesting, but calling it proven is inaccurate by any standard scientific definition.

She also deserves credit for what she did not claim. She did not say these peptides cure ADHD. She did not recommend a specific dose. She disclosed her source, acknowledged her non-medical status, and framed the results as her own experience after four weeks of use. That level of transparency is not common in this content category. Her subjective report of faster mental clarity on symptomatic days is plausible given semax's proposed mechanism, but placebo effect at four weeks cannot be ruled out without a controlled comparison.

What should you actually know?

Semax and selank are not FDA-approved for any indication. In the United States, they can only be obtained through compounding pharmacies operating under specific regulatory conditions. The quality, purity, and dosing consistency of compounded peptides vary by pharmacy and are not held to the same manufacturing standards as FDA-approved drugs. Anyone considering these compounds should know that long-term human safety data is essentially absent in peer-reviewed literature outside of small Russian trials.

For adults over 50 who cannot tolerate stimulant medications, there are FDA-approved non-stimulant options including atomoxetine (Strattera), viloxazine (Qelbree), and guanfacine (Intuniv) that have documented safety profiles in adults. The claim that there is "not a lot out there" besides Adderall for older adults with ADHD is not accurate, and anyone in that situation should speak with a psychiatrist before turning to compounded peptides as a first alternative.

If you are curious about semax or selank, a licensed prescriber familiar with peptide pharmacology should be part of that conversation, not a TikTok comment section.